CATHERINE D'ANJOU: Open Payments
NPI 1023773389 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,123 in 89 payments from 18 companies in 2025. Trend: 2023 $448 · 2024 $702 · 2025 $2,123
Food & beverage: $2,123
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $368 |
| Axsome Therapeutics, Inc. | 7 | $266 |
| Otsuka America Pharmaceutical, Inc. | 7 | $256 |
| Alkermes, Inc. | 13 | $251 |
| Neurocrine BioSciences, Inc. | 6 | $173 |
| ABBVIE INC. | 12 | $154 |
| Teva Pharmaceuticals USA, Inc. | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 3 | $88 |
| Lundbeck LLC | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
Products named: CAPLYTA, ARISTADA, Auvelity, REXULTI, INGREZZA, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
